基本信息
浏览量:0
职业迁徙
个人简介
His main research interests are in early clinical development, phase I trials across solid tumours, pharmacodynamic biomarkers, early phase II trials and sarcoma. He is also involved in translational research aspects related to sensitivity and resistance to targeted therapies, notably in soft-tissue sarcoma models.
He is a peer reviewer for several oncology journals and has contributed to over 200 peer-reviewed publications, including publications as first or last author in the Lancet Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.
He is a peer reviewer for several oncology journals and has contributed to over 200 peer-reviewed publications, including publications as first or last author in the Lancet Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.
研究兴趣
论文共 40 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alban Bessede,Florent Peyraud, Benjamin Besse,Sophie Cousin,Mathilde Cabart,Francois Chomy,Christophe Rey, Oren Lara, Ophelie Odin,Imane Nafia,Lucile Vanhersecke,Fabrice Barlesi,
Stéphane Champiat,Philippe Cassier, Nuria Kotecki,Carlos Gomez‐Roca,Iphigénie Korakis, K. Ouali,Antoîne Italiano,Mabrouk Elgadi,Thomas Vandewalle,Isabelle Girault, Nina Salabert, Donogh O’Brien,
Cancer Researchno. 7_Supplement (2023): 2129-2129
引用0浏览0引用
0
0
Journal for ImmunoTherapy of Cancerno. Suppl 2 (2023)
引用0浏览0引用
0
0
Annals of oncology : official journal of the European Society for Medical Oncologyno. 12 (2023): 1090-1093
引用0浏览0WOS引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 113368-113368
M. Tagliamento, C. Marzac,M. Aldea, D. Vasseur,A. Bayle, A. Gazzah,M. Ngocamus, C. Nicotra,A. Levy,C. Baldini, F. Blanc-Durand,E. Rouleau,
Journal of Thoracic Oncologyno. 11 (2023): S258-S258
引用0浏览0WOS引用
0
0
The Journal of Liquid Biopsy (2023): 100059-100059
CLINICAL CANCER RESEARCHno. 23 (2023): 4883-4893
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn